Winett James M sold $40K of NUS

Winett James M sold 7,203 shares of NU SKIN ENTERPRISES, INC. (NUS) at $5.62 on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Winett James M
Published Jun 3, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NUS
Neutral
medium confidence
Mentioned
$NUS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NUSNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may slightly influence sentiment, but it is not a fundamental catalyst by itself.

02

Market read

A single director’s 10b5-1 sale at a stated price is unlikely to drive a durable repricing without additional operational/financial news.

03

What to watch

The filing doesn’t reveal motives or whether future sales are planned beyond the current 10b5-1 schedule; compare with prior Form 4 patterns and total insider ownership changes.

Relevance 7/10Novelty 6/10Timing: SEC Form 4 filed after-hours (2026-06-03), covering a sale on 2026-06-02

Background

The article is an SEC insider transaction disclosure (Form 4) for Nu Skin Enterprises, Inc. involving a director sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$NUSNeutralMedium confidence
Context

Nu Skin Enterprises director sold 7,203 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely minimal near-term impact; any effect would be sentiment/flow-related rather than fundamental.

Evidence & confidence

The filing provides a specific sale size and price, but the presence of a pre-arranged 10b5-1 plan reduces interpretability as a new negative view.

Market effects

Limited; this is company-specific insider activity with no stated sector-wide development.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with weaker near-term expectations; traders may watch for follow-on sales.

Key entities

  • NU SKIN ENTERPRISES, INC.

    Subject of the SEC Form 4 insider transaction; director sold shares under a 10b5-1 plan.

  • Winett James M

    Director who executed the open-market sale disclosed in the Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NUSHigh

Nu Skin: Q3 Earnings Snapshot

Nu Skin Enterprises (NUS) reported a Q3 loss of $742,000, or 2 cents per share. Adjusted earnings were 10 cents per share. Revenue was $311 million. The company forecasts Q4 EPS of 11-21 cents and full-year EPS of 55-65 cents.

$NUSMed

Nu Skin Enterprises Reports Third Quarter Earnings

NU SKIN ENTERPRISES, INC. (NUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Third Quarter Earnings PROVO, Utah — Nov. 5, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter revenue within its guidance range. Executive Summary Q3 2026 vs. Prior-year Quarter Revenue $311.0

$NUSMed

Nu Skin Reports Q2 2026 Financial Results

Nu Skin Enterprises reported Q2 2026 results. Revenue was $320.1M and gross margin was 68.2% versus 68.8% in Q2 2025. Q3 revenue guidance is $310M to $340M with EPS $0 to $0.09. Full-year 2026 revenue is guided to $1.28B to $1.35B and adjusted EPS to $0.70 to $0.90, per company statements.

$NUSMed

Nu Skin Enterprises Reports Second Quarter Results

NU SKIN ENTERPRISES, INC. (NUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Nu Skin Enterprises Reports Second Quarter Results PROVO, Utah — Aug. 10, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results. Executive Summary Q2 2026 vs. Prior-year Quarter Revenue $320.1 million; (17.1)% • (1.0